Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

Why Ginkgo Bioworks Stock Is Falling After Hours

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower in Monday's after-hours session after the company reported financial results.

Ginkgo Bioworks said first-quarter revenue increased 282% year-over-year to $168 million, which beat the $105.68-million estimate, according to data from Benzinga Pro. The company said it added 11 new cell programs in the first quarter, representing 175% growth year-over-year.

Ginkgo Bioworks highlighted its recently announced plans to expand platform capabilities in agricultural biologicals through a series of M&A transactions and flagship collaborations with Bayer. The company said it ended the quarter with $1.5 billion in cash. 

Ginkgo Bioworks raised its full-year revenue guidance from a range of $325 million to $340 million to a range of $375 million to $390 million. The company said it expects to add 60 new cell programs to its Foundry platform in 2022. 

DNA 52-Week Range: $2.09 - $15.86

The stock was down 3.69% in after-hours at $2.37 at press time.

Photo: Vic_B from Pixabay.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.